Literature DB >> 18339588

Simultaneous quantification of four active schisandra lignans from a traditional Chinese medicine Schisandra chinensis(Wuweizi) in rat plasma using liquid chromatography/mass spectrometry.

Bao-Lian Wang1, Jin-Ping Hu, Wei Tan, Li Sheng, Hui Chen, Yan Li.   

Abstract

A simple, rapid and sensitive method was developed for the simultaneous quantification of four active schisandra lignans (schisandrin, schisantherin A, deoxyshisandrin and gamma-schisandrin) from a traditional Chinese medicine Schisandra chinensis(Wuweizi) in rat plasma using a high-performance liquid chromatography system coupled to a positive ion electrospray mass spectrometric analysis. The plasma sample preparation was a simple deproteinization by the addition of three volumes of methanol followed by centrifugation. The analytes and internal standard (IS) bicyclol were separated on a Zorbax SB-C18 column (3.5 microm, 2.1 mm x 100 mm) with mobile phase of methanol/water (70:30, v/v) containing 0.1% formic acid at a flow rate of 0.2 mL/min with an operating temperature of 25 degrees C. Detection was performed on a Trap XCT mass spectrometer equipped with an electrospray ionization (ESI) source operated in selected ion monitoring (SIM) mode. Positive ion ESI was used to form sodium adduct molecular ions at m/z 455 for schisandrin, m/z 559 for schisantherin A, m/z 439 for deoxyshisandrin, m/z 423 for gamma-schisandrin, and m/z 413 for the internal standard bicyclol. Linear detection responses were obtained for the four test compounds ranging from 0.010 to 2.0 microg/mL and the lower limits of quantitation (LLOQs) for four lignans were 0.010 microg/mL. The intra- and inter-day precisions (R.S.D.%) were within 12.5% for all analytes, while the deviation of assay accuracies was within +/-13.0%. The average recoveries of analytes were greater than 80.0%. All analytes were proved to be stable during all sample storage, preparation and analytic procedures. The method was successfully applied to the pharmacokinetic study of the four lignans after oral administration of Schisandra chinensis extraction to rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339588     DOI: 10.1016/j.jchromb.2008.02.016

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Synergy and Antagonism of Active Constituents of ADAPT-232 on Transcriptional Level of Metabolic Regulation of Isolated Neuroglial Cells.

Authors:  Alexander Panossian; Rebecca Hamm; Onat Kadioglu; Georg Wikman; Thomas Efferth
Journal:  Front Neurosci       Date:  2013-02-20       Impact factor: 4.677

2.  Chinese medicines in the treatment of experimental diabetic nephropathy.

Authors:  Jing-Yi Liu; Xiao-Xin Chen; Sydney Chi-Wai Tang; Stephen Cho-Wing Sze; Yi-Bin Feng; Kai-Fai Lee; Kalin Yan-Bo Zhang
Journal:  Chin Med       Date:  2016-02-24       Impact factor: 5.455

3.  Second-order calibration applied to quantification of two active components of Schisandra chinensis in complex matrix.

Authors:  Xiao-Hua Zhang; Hai-Long Wu; Jian-Yao Wang; Yao Chen; Yong-Jie Yu; Chong-Chong Nie; Chao Kang; De-Zhu Tu; Ru-Qin Yu
Journal:  J Pharm Anal       Date:  2012-04-25

Review 4.  Applications of HPLC/MS in the analysis of traditional Chinese medicines.

Authors:  Miao Li; Xiao-Fang Hou; Jie Zhang; Si-Cen Wang; Qiang Fu; Lang-Chong He
Journal:  J Pharm Anal       Date:  2012-01-30

5.  The Cytochrome P450-Mediated Metabolism Alternation of Four Effective Lignans From Schisandra chinensis in Carbon Tetrachloride-Intoxicated Rats and Patients With Advanced Hepatocellular Carcinoma.

Authors:  Rongrong Wu; Zhiyong Xiao; Xiaorui Zhang; Feng Liu; Wenxia Zhou; Yongxiang Zhang
Journal:  Front Pharmacol       Date:  2018-03-14       Impact factor: 5.810

6.  Pharmacokinetics of Schizandrin and Its Pharmaceutical Products Assessed Using a Validated LC-MS/MS Method.

Authors:  Chi-Lin Li; Yung-Yi Cheng; Chen-Hsi Hsieh; Tung-Hu Tsai
Journal:  Molecules       Date:  2018-01-15       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.